Financial Incentives for Weight Reduction Study
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 1/27/2019 |
| Start Date: | October 16, 2017 |
| End Date: | June 2022 |
| Contact: | Stephanie Orstad, PhD. |
| Email: | stephanie.orstad@nyumc.org |
| Phone: | 212-263-4143 |
Financial Incentive Strategies for Weight Loss in Obese Patients Living in Socioeconomically Disadvantaged Neighborhoods
Financial incentives for motivating changes in health behavior, particularly for weight loss
in obese individuals, are increasingly being tested by health insurers, employers, and
government agencies. However, a key unanswered question regarding weight loss is how to
structure these incentive programs to maximize their effectiveness, acceptability to
patients, and economic sustainability. Focusing on obese patients living in neighborhoods
with a high concentration of low socioeconomic status households, the investigators will
compare the impact of financial incentives for weight loss on sustained weight loss, use of
evidenced-based therapy, and quality of life, and they will determine their short-term and
long-term return on investment.
in obese individuals, are increasingly being tested by health insurers, employers, and
government agencies. However, a key unanswered question regarding weight loss is how to
structure these incentive programs to maximize their effectiveness, acceptability to
patients, and economic sustainability. Focusing on obese patients living in neighborhoods
with a high concentration of low socioeconomic status households, the investigators will
compare the impact of financial incentives for weight loss on sustained weight loss, use of
evidenced-based therapy, and quality of life, and they will determine their short-term and
long-term return on investment.
Financial incentives for motivating changes in health behavior, for weight loss in obese
individuals, are increasingly being tested by health insurers, employers, and government
agencies. However, a key unanswered question regarding weight loss is how to structure these
incentive programs to maximize their (1) effectiveness, underscored by the fact that most
programs have not resulted in significant long-term weight loss; and (2) economic
sustainability, as defined by their return on investment—a major factor in public and private
decision-making.
Obese patients represent an important population to target for effective weight loss
interventions because they suffer from a high prevalence of serious obesity-related
illnesses—including diabetes, hypertension, dyslipidemia, heart disease, stroke, sleep apnea,
and cancer—disproportionately have a low socioeconomic status, and impose $147 billion in
costs on the healthcare system annually. While prior studies testing financial incentives in
this population have had variable short-term success and few have yielded long-term weight
loss, a fundamental question remains unanswered and may partially explain variability in
weight loss outcomes: specifically, it is unknown whether goal-directed incentives
(incentives for achieving evidence-based, intermediate goals that increase weight loss but
are underutilized, like dietary counseling, physical activity, behavioral self-monitoring,
and intensive weight management programs) or outcome-based incentives (like incentives for
successfully losing weight) are more effective for promoting weight loss. Prior studies of
weight loss incentives have largely emphasized only the latter.
The investigators propose a three-arm randomized controlled trial that will address this
important knowledge gap among obese patients living in socioeconomically disadvantaged
neighborhoods, with implications for other serious chronic health conditions. Comparing
goal-directed incentives to outcome-based incentives and usual care, the investigators will
assess their impact on weight loss (≥5% of baseline weight), use of evidenced-based therapy,
and quality of life, and evaluate their short-term and long-term return on investment.
individuals, are increasingly being tested by health insurers, employers, and government
agencies. However, a key unanswered question regarding weight loss is how to structure these
incentive programs to maximize their (1) effectiveness, underscored by the fact that most
programs have not resulted in significant long-term weight loss; and (2) economic
sustainability, as defined by their return on investment—a major factor in public and private
decision-making.
Obese patients represent an important population to target for effective weight loss
interventions because they suffer from a high prevalence of serious obesity-related
illnesses—including diabetes, hypertension, dyslipidemia, heart disease, stroke, sleep apnea,
and cancer—disproportionately have a low socioeconomic status, and impose $147 billion in
costs on the healthcare system annually. While prior studies testing financial incentives in
this population have had variable short-term success and few have yielded long-term weight
loss, a fundamental question remains unanswered and may partially explain variability in
weight loss outcomes: specifically, it is unknown whether goal-directed incentives
(incentives for achieving evidence-based, intermediate goals that increase weight loss but
are underutilized, like dietary counseling, physical activity, behavioral self-monitoring,
and intensive weight management programs) or outcome-based incentives (like incentives for
successfully losing weight) are more effective for promoting weight loss. Prior studies of
weight loss incentives have largely emphasized only the latter.
The investigators propose a three-arm randomized controlled trial that will address this
important knowledge gap among obese patients living in socioeconomically disadvantaged
neighborhoods, with implications for other serious chronic health conditions. Comparing
goal-directed incentives to outcome-based incentives and usual care, the investigators will
assess their impact on weight loss (≥5% of baseline weight), use of evidenced-based therapy,
and quality of life, and evaluate their short-term and long-term return on investment.
Inclusion Criteria:
- English or Spanish-speaking patients
- Under the care of a primary care physician at Manhattan VA, Bellevue, NYU Langone
Medical Center, or Olive View-UCLA Medical Center
- With obesity, based on BMI of 30 to 40 kg/m2 during a prior visit in the past 6 months
- Who are between the age of 18 and 70 years
- Who have an active U.S. phone number and address
Exclusion Criteria:
- have had weight loss ≥4.5 kg
- participated in an intensive weight loss program in the past 6 mo
- abuse alcohol/other substances
- have active psychosis/other cognitive issues
- have history of myocardial infarction/stroke in the past 6 mo. or metastatic cancer
- New York Heart Association Class III/IV heart failure
- Chronic Kidney Disease stage IV/V
- pregnant or breastfeeding or plan to become pregnant within subsequent 12 mo.
- have history of an eating disorder/unsafe weight-loss behaviors
- are unable to provide informed consent
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials